Veradermics (MANE), a biopharmaceutical company focused on hair restoration, said late Tuesday it priced an upsized initial public offering of 15,077,647 common shares at $17 apiece for about $256.3 million in expected gross proceeds.
IPO underwriters have a 30-day overallotment option to purchase up to 2,261,647 additional shares.
The company said it expects its shares to start trading on the New York Stock Exchange under the ticker symbol MANE Wednesday, while the IPO is expected to close Thursday.